Evidence map›Paper›PMID 33973017›Full record

ArticleDiabetologia2021

Genetic predisposition in the 2'-5'A pathway in the development of type 1 diabetes: potential contribution to dysregulation of innate antiviral immunity.

Kristina Pedersen, Martin Haupt-Jorgensen, Lars Krogvold, Simranjeet Kaur, Ivan C Gerling, Flemming Pociot, Knut Dahl-Jørgensen, Karsten Buschard

Open access · hybridAbstract read
In one paragraph

Article in Diabetologia, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Beta-cell activity and development of Type 1 diabetes.APMIS : acta pathologica, microbiologica, et immunologica Scandinavica · 2025
    Review
  4. Redox regulation of mNature cell biology · 2024
    Article
  5. Article
  6. Article
  7. Applications of Genome-Editing Technologies for Type 1 Diabetes.International journal of molecular sciences · 2023
    Review
  8. Article
  9. Article
  10. PDE12 in type 1 diabetes.Scientific reports · 2022
    Article
  11. Review
  12. Review
  13. Article
  14. 2-5A-Mediated decay (2-5AMD): from antiviral defense to control of host RNA.Critical reviews in biochemistry and molecular biology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Kristina PedersenThe Bartholin Institute, Department of Pathology, Rigshospitalet, Copenhagen, Denmark. kristina.pedersen@regionh.dk.ORCID 0000-0001-5135-6021
Martin Haupt-JorgensenThe Bartholin Institute, Department of Pathology, Rigshospitalet, Copenhagen, Denmark.ORCID 0000-0003-4088-5862
Lars KrogvoldDivision of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.
Simranjeet KaurSteno Diabetes Center Copenhagen, Gentofte, Denmark.ORCID 0000-0003-0490-1028
Ivan C GerlingDepartment of Medicine, University of Tennessee, Memphis, TN, USA.
Flemming PociotSteno Diabetes Center Copenhagen, Gentofte, Denmark.ORCID 0000-0003-3274-5448
Knut Dahl-JørgensenDivision of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.ORCID 0000-0002-6952-9899
Karsten BuschardThe Bartholin Institute, Department of Pathology, Rigshospitalet, Copenhagen, Denmark.ORCID 0000-0002-0126-7423
Rigshospitalet · DKOslo University Hospital · NOSteno Diabetes Centers · DKUniversity of Copenhagen · DKUniversity of Tennessee Health Science Center · US

Funding

Defining Islet Heterogeneity Using Single Islet TranscriptomicsUC4DK104155 · NIDDK · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI CAMPBELL-THOMPSON, MARTHA, GERLING, IVAN C · 2014 to 2014
$1.6M
NIDDK NIH HHS UC4 DK104155
6 · The paper itself

Abstract

aims/hypothesisThe incidence of type 1 diabetes is increasing more rapidly than can be explained by genetic drift. Viruses may play an important role in the disease, as they seem to activate the 2'-5'-linked oligoadenylate (2'-5'A) pathway of the innate antiviral immune system. Our aim was to investigate this possibility.

methodsInnate antiviral immune pathways were searched for type 1 diabetes-associated polymorphisms using genome-wide association study data. SNPs within ±250kb flanking regions of the transcription start site of 64 genes were examined. These pathways were also investigated for type 1 diabetes-associated RNA expression profiles using laser-dissected islets from two to five tissue sections per donor from the Diabetes Virus Detection (DiViD) study and the network of Pancreatic Organ Donors (nPOD).

resultsWe found 27 novel SNPs in genes nominally associated with type 1 diabetes. Three of those SNPs were located upstream of the 2'-5'A pathway, namely SNP rs4767000 (p = 1.03 × 10 CONCLUSIONS/

interpretationWe identified a genetic predisposition in the 2'-5'A pathway that potentially contributes to dysregulation of the innate antiviral immune system in type 1 diabetes. This study describes a potential role for the 2'-5'A pathway and other components of the innate antiviral immune system in beta cell autoimmunity.

Indexed as

Genetic Predisposition to DiseaseAdenine NucleotidesAdultAntiviral AgentsDiabetes Mellitus, Type 1FemaleGene Expression RegulationGenome-Wide Association StudyHumansImmunity, InnateMaleOligoribonucleotidesPolymorphism, Single NucleotideRNA-Binding ProteinsRNA, MessengerVirus Diseases2',5'-oligoadenylateAdenine NucleotidesAntiviral AgentsOligoribonucleotidesRNA-Binding ProteinsRNA, Messenger2′-5′A pathway2′-5′ Oligoadenylate synthetaseInterferon αRibonuclease LRNase LToll-like receptor 7Type 1 diabetesType 1 interferonType 2 diabetesVirus

Identifiers

PMID33973017
PMCPMC8245375
OpenAlexW3161202580

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.